Halaman 2 - Onkologi Ahli onkologi Terbaik di Espanha - TOP-44 dokter

Forbes menobatkan Dr. Tabernero sebagai salah satu dari 5 onkolog terbaik di Spanyol – pemimpin dalam terapi kanker personal di Rumah Sakit Quiron Barcelona.

• Mantan Presiden European Society for Medical Oncology
• Spesialisasi dalam terapi target molekuler dan pengembangan obat baru
• Melakukan uji klinis untuk pengobatan kanker usus besar stadium lanjut
• Pengalaman lebih dari 20 tahun dalam onkologi gastrointestinal
• Penasihat Kementerian Kesehatan Spanyol

Ahli dalam terapi kanker personal dan imunoterapi dengan lebih dari 30 tahun praktik onkologi – memimpin perawatan terobosan di Quironsalud Torrevieja.

• Mempelopori transplantasi sumsum tulang autologus dan kemoterapi dosis tinggi
• Spesialisasi dalam microarray RNA dan farmakogenomik untuk perawatan yang disesuaikan
• Fellowship lanjutan dalam imunoterapi di Cleveland Clinic
• Menerbitkan lebih dari 120 makalah tentang penelitian kanker
• Anggota AACR, ASCO, dan ASH

Lebih dari 35 tahun memimpin departemen onkologi di berbagai rumah sakit besar di Spanyol – Dr. Joseba Rebollo Liceaga berspesialisasi dalam perawatan kanker multidisiplin di Quironsalud Torrevieja.

• Spesialisasi dalam Onkologi Medis di Clínica Universidad de Navarra
• Mempublikasikan penelitian tentang pengobatan inovatif seperti elektrokemoterapi
• Mantan Kepala Onkologi di berbagai rumah sakit bergengsi
• Mengajar calon ahli onkologi sebagai mantan dokter rekanan universitas

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Dr. Prat memimpin uji klinis SOLTI, yang berfokus pada ekspresi gen dan subtipe molekuler kanker payudara. Penelitiannya diterjemahkan langsung ke dalam pendekatan pengobatan yang dipersonalisasi.

• Kepala Genomik Translaksional di IDIBAPS – mengintegrasikan temuan laboratorium ke dalam perawatan pasien
• Presiden SOLTI – merancang pengobatan kanker payudara baru
• Memegang tiga paten dalam diagnostik kanker payudara
• Lebih dari 160 publikasi dengan 13.479 sitasi
• Profesor jalur masa jabatan di Universitas Barcelona

Peneliti Utama dalam berbagai uji klinis untuk kanker ovarium, serviks, dan endometrium – Dr. Oaknin menghadirkan penelitian tingkat lanjut secara langsung ke perawatan pasien.

• Ahli terkemuka dalam angiogenesis dan perbaikan DNA untuk kanker ginekologi
• Penulis 100+ publikasi dan presentasi di bidang onkologi
• Wakil Ketua GEICO, kelompok riset kanker ovarium Spanyol
• Anggota fakultas untuk Gyn-Track di ESMO dan anggota ASCO

Pediatric orthopedist-traumatologist, specializes in surgical oncology

15 years of experience

• 
  
• He passed specialization in orthopedic surgery and traumatology at the Children's Research Hospital of St. Jude in Memphis, USA (2007-2008).
• Dr. Thorner Rubins currently teaches at the University of Barcelona.
• Нe is the head of the Department of Orthopedics and Traumatology at the Hospital Sant Joan de Déu in Barcelona.

Dr. Soberino telah berkontribusi pada uji coba penting yang merevolusi pengobatan melanoma dengan obat-obatan seperti Pembrolizumab dan Nivolumab.

• Spesialisasi dalam imunoterapi untuk melanoma di Hospital Quiron Barcelona
• Peserta utama dalam uji coba yang menghasilkan obat-obatan yang disetujui FDA
• Anggota Unit Melanoma Vall d’Hebron, pusat onkologi terkemuka
• Berfokus pada mengatasi resistensi terapi hormon pada kanker payudara

15.000+ prosedur bedah dilakukan – Dr. de Lacy adalah pionir dalam teknik invasif minimal untuk kanker kolon dan rektum di Rumah Sakit Quiron Barcelona.

• Melakukan 1.000+ intervensi setiap tahun menggunakan metode laparoskopi dan robotik
• Pionir terkenal di dunia dalam teknik bedah gastrointestinal
• Presiden Asosiasi Ahli Bedah-Endoskopi di Eropa
• Pendiri teknik TaTME untuk bedah kanker rektum

Spesialis dalam pengobatan retinoblastoma di SJD Barcelona Children's Hospital – pusat terkemuka untuk onkologi pediatrik.

• Berfokus secara eksklusif pada kanker mata anak
• Bekerja di salah satu rumah sakit anak terbaik di Eropa
• Ahli dalam pengobatan mutakhir untuk retinoblastoma

Mempelopori kriteria diagnostik untuk sindrom neurologis paraneoplastik – Dr. Graus adalah tokoh terkemuka dalam neuro-onkologi di Hospital Quiron Barcelona.

• Pendiri dan mantan presiden European Association of Neuro-Oncology
• Spesialisasi dalam glioma, limfoma otak, dan neurotoksisitas terkait pengobatan
• Terlatih dalam neuro-onkologi di Memorial Sloan-Kettering Cancer Center
• Mantan Kepala Neurologi di Hospital Clinic Barcelona
• Dianugerahi Doctor Honoris Causa oleh Universitas Lyon

Profesor Bosch adalah pemimpin yang diakui secara global dalam Leukemia Limfositik Kronis (CLL), merintis pengobatan baru dan teknologi diagnostik.

• Memimpin 80+ uji klinis dari fase 1 hingga fase 3
• Kepala Hematologi di Rumah Sakit Universitas Vall d'Hebron
• Menerbitkan 100+ artikel di jurnal medis terkemuka
• Spesialisasi dalam patogenesis molekuler CLL
• Presiden kelompok studi CLL Spanyol (GELLC)

Dr. Lopez Ibor memimpin Unit Hematologi dan Onkologi Anak di HM Montepríncipe dengan pengalaman lebih dari 20 tahun yang didedikasikan untuk kanker masa kanak-kanak.

• Spesialisasi dalam tumor tulang dan otak, leukemia, dan penyakit hematologi
• Menempuh pendidikan Hematologi dan Onkologi Anak di University of Maryland
• Penulis berbagai publikasi ilmiah nasional dan internasional
• Sebelumnya mengepalai onkologi anak di Clínica San Rafael

Direktur penelitian pascasarjana di bidang onkologi klinis dan terapan – Dr. Cubillo Gracián melatih spesialis masa depan di HM CIOCC sambil menangani kanker sistem pencernaan.

• Spesialisasi dalam neoplasma pencernaan dan tumor neuroendokrin pankreas
• Mengajar kursus onkologi di universitas USP CEU
• Menempuh pendidikan di MD Anderson Cancer Center
• Memimpin kursus internasional tentang patologi sistem pencernaan

Dr. Joan Albanell Mestres memimpin program kanker payudara di HM Delfos, dengan pengalaman lebih dari 30 tahun dan 120+ artikel yang diterbitkan dalam bidang onkologi.

• Spesialisasi dalam pengobatan dan penelitian kanker payudara
• Kepala layanan Onkologi di Clin del Mar
• Melakukan penelitian terobosan tentang telomerase di New York
• Anggota terkemuka GEICAM, CIBERONC, AIECA, dan SEOM
• Direktur program penelitian kanker di Del Mar

Lebih dari 140 artikel yang diterbitkan tentang kanker urologi – Dr. Mellado Gonzalez memimpin penelitian translasi di institut IDIBAPS Hospital Clínic de Barcelona.

• Spesialisasi dalam kanker prostat, ginjal, kandung kemih, dan testis
• Penyelidik utama untuk berbagai uji klinis pada terapi baru
• Associate Professor di Fakultas Kedokteran Universitas Barcelona
• Mengajar uro-onkologi di tingkat master dan mensupervisi tesis doktoral